Análisis de la longitud telomérica como biomarcador del riesgo y progresión de enfermedades metabólicas
Revista Bioquímica y Patología Clínica · 2025
DOI: 10.62073/73w1gh43 ↗Abstract
Objectives: To analyze telomere length (LT) as a biomarker of risk and progression of metabolic diseases and to evaluate the TL according to the number of metabolic alterations and environmental risk factors. Materials and Methods: We performed a cross-sectional study of 1006 individuals categorized into: metabolically healthy individuals with obesity (OMS); obesity and metabolic syndrome (OSM) and a normal weight control group (NP). Biochemical-clinical and anthropometric determinations were made and the presence of lifestyle risk factors and pre-existing diseases were self-reported. The absolute LT in peripheral blood DNA was determined by quantitative PCR. Statistical analysis was performed with SPSS v20.0 with p
EUVIMED